Published on:

FDA plans to warn about potential Tamoxifen drug interaction

The FDA plans to warn physicians about potential drug interactions between the breast-cancer drug tamoxifen and certain antidepressants. Product safety studies showed women on both drugs were more than twice as likely to see their cancer return.

To read more about the drug interactions.